in a subset of patients with RA who have HLA-DR alleles encoding the shared epitope (SE), could trigger rheumatoid arthritis (RA)-specific immune reactions to citrullinated proteins. Several ...

The technology was announced at the JP Morgan Healthcare Conference in San Francisco. In this project, the stakeholders aim to use a human reference genome to combine with patient data in order to try ...

Cerebras Systems has teamed with Mayo Clinic to create an AI genomic foundation model that predicts the best medical treatments.

Cerebras Systems (a client of Cambrian-AI Research) announced a new foundation model co-developed with partner The Mayo ...

Rheumatoid arthritis is a crippling condition affecting 1.3 million people. To date, the standard of care has been to head ...

Clinical and Radiographic Outcomes of Four Different Treatment Strategies in Patients With Early Rheumatoid Arthritis (the Best Study): A Randomized, Controlled Trialfrom Arthritis & Rheumatism.

Lee et al. assessed the efficacy of the proteasome inhibitor bortezomib on collagen-induced arthritis (CIA), a mouse model of rheumatoid arthritis. Two doses of type II collagen, administered 2 ...

Cerebras Systems, in collaboration with Mayo Clinic, announced significant progress in developing artificial intelligence ...

Autoimmune diseases that cause damage and inflammation inside the body include rheumatoid arthritis ... the first device are working on a new model. This new implant is tiny – all the components ...